| 0 (0%) | 02-21 18:40 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.76 | 1-year : | 3.23 |
| Resists | First : | 2.36 | Second : | 2.76 |
| Pivot price | 1.93  |
|||
| Supports | First : | 1.89 | Second : | 1.6 |
| MAs | MA(5) : | 2.11 |
MA(20) : | 1.93 |
| MA(100) : | 2.26 |
MA(250) : | 2.42 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 65.3 |
D(3) : | 67.3 |
| RSI | RSI(14): 52.6 |
|||
| 52-week | High : | 4.67 | Low : | 1.25 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ MBOT ] has closed below upper band by 32.6%. Bollinger Bands are 15.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.14 - 2.15 | 2.15 - 2.16 |
| Low: | 2.02 - 2.03 | 2.03 - 2.05 |
| Close: | 2.04 - 2.06 | 2.06 - 2.08 |
Thu, 19 Feb 2026
Microbot Medical (MBOT) CEO to Speak at Surgical Technology Summ - GuruFocus
Thu, 19 Feb 2026
Single-use surgery robot aims to cut radiation in vascular care - Stock Titan
Wed, 18 Feb 2026
$2.12 Pre Market 18 Feb 2026: MBOT Microbot Medical Inc NASDAQ – 91% upside - Meyka
Fri, 13 Feb 2026
Assessing Microbot Medical (MBOT) Valuation As LIBERTY Robotic System Advances Toward Full Market Release - simplywall.st
Tue, 27 Jan 2026
We're Not Very Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Rate - Sahm
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 67 (M) |
| Shares Float | 67 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 15.6 (%) |
| Shares Short | 6,830 (K) |
| Shares Short P.Month | 6,420 (K) |
| EPS | -0.45 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.19 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -20.2 % |
| Return on Equity (ttm) | -31.9 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.21 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -11 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -4.58 |
| PEG Ratio | 0 |
| Price to Book value | 1.73 |
| Price to Sales | 0 |
| Price to Cash Flow | -12.61 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|